Skip to main content
. 2022 Oct 28;37(1):47–58. doi: 10.7555/JBR.36.20220156

Figure 2.

Figure 2

p53 pathway in glioblastoma multiforme invasion.

The alteration of p53 can be mainly attributed to TP53 mutation, CDKN2A/ARF deletion, and MDM2 amplification, which leads to CSC proliferation, enabling the tumor to escape destruction and evolve into more invasive phenotypes. TP53: tumor protein p53; CDKN2A: cyclin dependent kinase inhibitor 2A; MDM2: mouse double minute 2; CSC: cancer stem cell.